Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
July 10, 2013 -- Tianjin Weikai obtained exclusive China rights to manufacture and distribute TissueFlex® from Zyoxel Limited of Oxford, UK. TissueFlex® is a microbioreactor for 3D perfused cell culture. Zyoxel will receive royalties for each system sold. Zyoxel and Weikai both focus on stem cell technologies. Weikai offers stem cell CRO services and products. More details....
Help employers find you! Check out all the jobs and post your resume.
